In some ways, 2025 was when AI dictation apps really took off. Dictation apps have been around for years, but in the past ...
Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback